Hwang Jonathan J, Dharmawardana Pathirage G, Uchio Edward M, Wynberg Jason, Phillips John L
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1501, USA.
Urology. 2003 Nov;62(5):941. doi: 10.1016/s0090-4295(03)00693-9.
Prostate cancer detection is a rare occurrence in patients with Klinefelter syndrome, in whom chronically low circulating androgen levels are common findings. Administration of exogenous testosterone has increasingly been used to treat young adolescents diagnosed with Klinefelter syndrome and documented androgen deficiency. Although testosterone replacement in adult patients has been associated with prostatic enlargement, it remains unknown whether chronic supplementation of exogenous testosterone to pubescent males with hypogonadism results in early prostate carcinogenesis. We report a first case of prostate cancer in a patient with Klinefelter syndrome who had undergone long-term testosterone replacement therapy since childhood for chronically depressed levels of testosterone.
在克兰费尔特综合征患者中,前列腺癌的检测极为罕见,这类患者常伴有长期循环雄激素水平低下。外源性睾酮给药越来越多地用于治疗被诊断为克兰费尔特综合征且有雄激素缺乏记录的青少年。尽管成年患者的睾酮替代治疗与前列腺增生有关,但对于青春期性腺功能减退男性长期补充外源性睾酮是否会导致早期前列腺癌发生仍不清楚。我们报告了首例克兰费尔特综合征患者发生前列腺癌的病例,该患者自童年起因睾酮水平长期低下接受了长期睾酮替代治疗。